Contenu éducatif de l'AUC

CUA Highlights of SNMMI 2024

Speakers: Patrick Martineau & Katherine Zukotynski

Objectives:

By participating in this learning program, healthcare providers can expect to:

  • Review key updates from SNMMI 2024 related to PSMA PET and PSMA-targeted RLT in prostate cancer
  • Discuss novel approaches to RLT currently being investigated in the area of prostate cancer
  • Examine the implications of new data for the management of patients with prostate cancer in Canadian clinical practice

SECTION 3 ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.


This program has received financial support from Novartis in the form of an educational grant.